Fast-Track Cardiovascular Assessment for Suspicion of Cardiovascular Events on Immunecheckpoint Inhibitors

Recruiting now

Conditions studied: Cancer, Immune Checkpoint Inhibitor, Cardiovascular Complication, Immune-related Adverse Event

In brief

Prospective study cohort on patients addressed for suspected cardiovascular event on immune checkpoint inchibitors. Longitudinal prospective single center cohort. Inclusion criteria: all patient willing to particiupate seen in the cardio-oncology unit at our institution for the suspicion of heart failure, atherosclerosis related event, Tako Tsubo, arrhymias, pericarditis, myocarditis on antiPD1, antiPDL1, or antiCTLA4 immune checkpoint inhibitors. Description of patients characteristics, investigations, diagnosis after multidisciplinary meeting, outcomes.

Key facts

Study ID

NCT05799898

Run by

Institut Mutualiste Montsouris

People needed

200

Starts

2022-03-01

Expected to finish

2030-01-01

Last updated by the study team

2023-04-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• all patient referred to the cardio oncology unit for suspected immune related cardiovascular complication on immune checkpoint inhibitors

You may not qualify if…

• none

Where it is running

• Intitut Mutualiste Montsouris — Paris, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.